Kalaris Therapeutics, Inc. financial statements
Kalaris Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 43.44M | 10-K |
| Cash and equivalents | USD 98.05M | 10-Q |
| Total debt | USD 1.45M | EODHD |
Kalaris Therapeutics, Inc. financials on 6ix · Kalaris Therapeutics, Inc. on 6ix